These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27148573)

  • 1. Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case.
    Knoechel B; Bhatt A; Pan L; Pedamallu CS; Severson E; Gutierrez A; Dorfman DM; Kuo FC; Kluk M; Kung AL; Zweidler-McKay P; Meyerson M; Blacklow SC; DeAngelo DJ; Aster JC
    Cold Spring Harb Mol Case Stud; 2015 Oct; 1(1):a000539. PubMed ID: 27148573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-secretase inhibitors suppress the growth of leukemia and lymphoma cells.
    Kogoshi H; Sato T; Koyama T; Nara N; Tohda S
    Oncol Rep; 2007 Jul; 18(1):77-80. PubMed ID: 17549349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors.
    O'Neil J; Grim J; Strack P; Rao S; Tibbitts D; Winter C; Hardwick J; Welcker M; Meijerink JP; Pieters R; Draetta G; Sears R; Clurman BE; Look AT
    J Exp Med; 2007 Aug; 204(8):1813-24. PubMed ID: 17646409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.
    Rao SS; O'Neil J; Liberator CD; Hardwick JS; Dai X; Zhang T; Tyminski E; Yuan J; Kohl NE; Richon VM; Van der Ploeg LH; Carroll PM; Draetta GF; Look AT; Strack PR; Winter CG
    Cancer Res; 2009 Apr; 69(7):3060-8. PubMed ID: 19318552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional analysis of notch in the pathophysiology of leukemia].
    Tohda S
    Rinsho Byori; 2009 Apr; 57(4):351-6. PubMed ID: 19489437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a new B-ALL cell line with constitutional defect of the Notch signaling pathway.
    Kamga PT; Dal Collo G; Bassi G; Midolo M; Delledonne M; Chilosi M; Bonifacio M; Krampera M
    Oncotarget; 2018 Apr; 9(26):18341-18350. PubMed ID: 29719609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicle microRNAs contribute to Notch signaling pathway in T-cell acute lymphoblastic leukemia.
    Colangelo T; Panelli P; Mazzarelli F; Tamiro F; Melocchi V; De Santis E; Cuttano R; Palumbo O; Rossi G; Bianchi F; Giambra V
    Mol Cancer; 2022 Dec; 21(1):226. PubMed ID: 36550553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia.
    Tan K; Xu J; Chen C; Vincent T; Pölönen P; Hu J; Yoshimura S; Yu W; Sussman J; Chen CH; Li E; Diorio C; Shraim R; Newman H; Uppuluri L; Li A; Chen G; Bandyopadhyay S; Wu D; Ding YY; Xu J; Lim T; Hsu M; Thadi A; Ahn KJ; Wu CY; Peng J; Sun Y; Wang A; Mehta R; Frank D; Meyer L; Loh M; Raetz E; Chen Z; Wood B; Devidas M; Dunsmore K; Winter S; Chang TC; Wu G; Pounds S; Zhang N; Carroll W; Hunger S; Bernt K; Yang J; Mullighan C; Teachey D
    Res Sq; 2023 Oct; ():. PubMed ID: 37961674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling.
    Suwanjunee S; Wongchana W; Palaga T
    Anticancer Drugs; 2008 Jun; 19(5):477-86. PubMed ID: 18418214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a homozygous JAK3 V674A mutation caused by acquired uniparental disomy in a relapsed early T-cell precursor ALL patient.
    Kawashima-Goto S; Imamura T; Seki M; Kato M; Yoshida K; Sugimoto A; Kaneda D; Fujiki A; Miyachi M; Nakatani T; Osone S; Ishida H; Taki T; Takita J; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Hosoi H
    Int J Hematol; 2015 Apr; 101(4):411-6. PubMed ID: 25430085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc.
    Sharma VM; Calvo JA; Draheim KM; Cunningham LA; Hermance N; Beverly L; Krishnamoorthy V; Bhasin M; Capobianco AJ; Kelliher MA
    Mol Cell Biol; 2006 Nov; 26(21):8022-31. PubMed ID: 16954387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel t(8;14)(q24;q11) Rearranged Human Cell Line as a Model for Mechanistic and Drug Discovery Studies of NOTCH1-Independent Human T-Cell Leukemia.
    Tosello V; Milani G; Martines A; Macri N; Van Loocke W; Matthijssens F; Buldini B; Minuzzo S; Bongiovanni D; Schumacher RF; Amadori A; Van Vlierberghe P; Piovan E
    Cells; 2018 Oct; 7(10):. PubMed ID: 30304769
    [No Abstract]   [Full Text] [Related]  

  • 16. IDH2-mutated near ETP-ALL with aggressive leukemia cutis and brisk response to venetoclax and decitabine.
    Vaidya P; Wang HY; Don MD; Hinds BR; Mangan JK
    Leuk Res Rep; 2024; 21():100408. PubMed ID: 38269085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors.
    Palomero T; Barnes KC; Real PJ; Glade Bender JL; Sulis ML; Murty VV; Colovai AI; Balbin M; Ferrando AA
    Leukemia; 2006 Jul; 20(7):1279-87. PubMed ID: 16688224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA profiling reveals aberrant microRNA expression in adult ETP-ALL and functional studies implicate a role for miR-222 in acute leukemia.
    Coskun E; Neumann M; Schlee C; Liebertz F; Heesch S; Goekbuget N; Hoelzer D; Baldus CD
    Leuk Res; 2013 Jun; 37(6):647-56. PubMed ID: 23522449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response.
    Shepherd C; Banerjee L; Cheung CW; Mansour MR; Jenkinson S; Gale RE; Khwaja A
    Leukemia; 2013 Mar; 27(3):650-60. PubMed ID: 23038273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951.
    Clappier E; Collette S; Grardel N; Girard S; Suarez L; Brunie G; Kaltenbach S; Yakouben K; Mazingue F; Robert A; Boutard P; Plantaz D; Rohrlich P; van Vlierberghe P; Preudhomme C; Otten J; Speleman F; Dastugue N; Suciu S; Benoit Y; Bertrand Y; Cavé H;
    Leukemia; 2010 Dec; 24(12):2023-31. PubMed ID: 20861920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.